Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SCHAEFER v. LANNETT COMPANY, INC. et al
Case Number:
2:14-cv-05008
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
October 17, 2014
Lannett Seeks Sanctions After Price-Fixing Suit Dropped
Lannett Company Inc. on Friday asked a Pennsylvania federal judge to slap a shareholder and his attorneys with sanctions for filing and then withdrawing a securities class action alleging that the generic-drug maker's executives hid a scheme to fix prices of the heart failure drug digoxin, contending that the "frivolous" suit was unsupported by facts.
-
August 28, 2014
Lannett Faces Shareholder Suit Over Price-Fixing Scheme
A shareholder on Wednesday filed a securities class action against generic-drug maker Lannett Company Inc. in a Pennsylvania federal court, saying Lannett's executives hid a scheme to fix the prices of the drug digoxin that led to its stock tanking when news of an investigation came out.